ロード中...
Bromocriptine alone or associated with L-dopa plus benserazide in Parkinson's disease.
Twenty-six patients affected by Parkinson's disease were treated with a 2-Br-alpha-ergocriptine (CB 154): 14 cases were given CB 154 alone, and 12 were given CB 154 along with L-dopa plus benserazide (Madopar). Both CB 154 and combined therapy (CB 154+Madopar) induced a significant improvement...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
1977
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC492936/ https://ncbi.nlm.nih.gov/pubmed/591982 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|